Medarion Pharma

Developing topical healthcare products for the UK market

Medarion Pharma is working to further develop two existing topical products, SkiNFiDAR® Skin Care Cream and DIAFAST® Topical Gel, for future UK-based manufacture and progression through the applicable regulatory pathways.

Both products are currently available in Iran. They are not currently manufactured, approved or available for sale in the UK.

Our products

Topical products in development for the UK market

SkiNFiDAR Skin Care Cream

SkiNFiDAR® Skin Care Cream

A topical cream formulated to moisturise, soothe and protect the skin.

Current availability: Iran

UK status: Product development and regulatory preparations in progress

Learn more about SkiNFiDAR®

DIAFAST Topical Gel

DIAFAST® Topical Gel

Topical gel developed for diabetic foot-wound care. Its development for the UK market may include formulation improvement, laboratory testing and clinical evaluation.

Current availability: Iran

UK status: Product development and regulatory preparations in progress

Learn more about DIAFAST®

Our UK development plans

Preparing products for the UK market

We aim to improve and prepare our products for the UK market through:

  • Formulation review and improvement
  • Laboratory, safety and performance evaluation
  • Advanced manufacturing and quality-control processes
  • Determination of the appropriate regulatory pathway for each product
  • Development of UK-based manufacturing arrangements
  • Collaboration with scientific, clinical, regulatory and commercial partners

Meet the team

Experience across science and healthcare

Medarion Pharma is led by a team with experience in pharmaceutical research, product development and healthcare. Together, we are working to further develop SkiNFiDAR® and DIAFAST® for the UK market.

Dr. Mehdi Sabzichi Radi

Dr. Mehdi Sabzichi Radi

Founder, Chief Executive Officer and Executive Director

Dr. Hossain Bijanpour

Dr. Hossain Bijanpour

Co-Founder and Board Member

Work with us

Partnership and investment opportunities

We welcome discussions with manufacturing, regulatory, scientific, clinical and commercial partners. We are also interested in speaking with investors who may support clearly defined product-development milestones.

WhatsApp Support

Scroll to Top